{
    "code": "02023472",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023472",
    "time": "2017-04-14 03:16:14",
    "許可證字號": "衛署藥輸字第023472號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/06\/18",
    "發證日期": "91\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202347209",
    "中文品名": "哲思膠囊８０毫克",
    "英文品名": "GEODON CAPSULES 80MG",
    "適應症": "思覺失調症、雙極性疾患之躁症發作及在雙極性疾患躁症發作(Bipolar I disorder)之維持治療中作為鋰鹽或valproate的輔助療法。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ZIPRASIDONEHYDROCHLORIDEMONOHYDRATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F020039000  PFIZER AUSTRALIA PTY LIMITED",
        "製造廠廠址": "38-42 WHARF ROAD, WEST RYDE, NSW 2114, AUSTRALIA",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "Z102100909",
            "成分名稱": "ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE",
            "含量描述": "",
            "含量": "90.6000000000",
            "單位": ""
        }
    ],
    "仿單外盒": [
        {
            "title": "Geodon Capsules LLD CDS 20150202-3(add ink name)-104-11-02(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023472&Seq=019&Type=9"
        },
        {
            "title": "Geodon 80mg 外盒包裝-104-09-25(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023472&Seq=001&Type=8"
        }
    ]
}